378 related articles for article (PubMed ID: 8393517)
1. Interaction of tricyclic drug analogs with synaptic plasma membranes: structure-mechanism relationships in inhibition of neuronal Na+/K(+)-ATPase activity.
Carfagna MA; Muhoberac BB
Mol Pharmacol; 1993 Jul; 44(1):129-41. PubMed ID: 8393517
[TBL] [Abstract][Full Text] [Related]
2. Na+, K+ ATPase activity is markedly reduced by cis-4-decenoic acid in synaptic plasma membranes from cerebral cortex of rats.
de Assis DR; Maria RC; Ferreira GC; Schuck PF; Latini A; Dutra-Filho CS; Wannmacher CM; Wyse AT; Wajner M
Exp Neurol; 2006 Jan; 197(1):143-9. PubMed ID: 16203000
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of rat synaptic membrane Na⁺/K⁺-ATPase and ecto-nucleoside triphosphate diphosphohydrolases by 12-tungstosilicic and 12-tungstophosphoric acid.
Čolović MB; Bajuk-Bogdanović DV; Avramović NS; Holclajtner-Antunović ID; Bošnjaković-Pavlović NS; Vasić VM; Krstić DZ
Bioorg Med Chem; 2011 Dec; 19(23):7063-9. PubMed ID: 22047804
[TBL] [Abstract][Full Text] [Related]
4. 5-HPETE is a potent inhibitor of neuronal Na+, K(+)-ATPase activity.
Foley TD
Biochem Biophys Res Commun; 1997 Jun; 235(2):374-6. PubMed ID: 9199200
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological characterization of ATPases in native synaptic vesicles and synaptic plasma membranes.
Obrdlik P; Diekert K; Watzke N; Keipert C; Pehl U; Brosch C; Boehm N; Bick I; Ruitenberg M; Volknandt W; Kelety B
Biochem J; 2010 Mar; 427(1):151-9. PubMed ID: 20100168
[TBL] [Abstract][Full Text] [Related]
6. Effect of diphenyl diselenide, diphenyl ditelluride and ebselen on cerebral Na(+), K(+)-ATPase activity in rats.
Borges VC; Rocha JB; Nogueira CW
Toxicology; 2005 Nov; 215(3):191-7. PubMed ID: 16095793
[TBL] [Abstract][Full Text] [Related]
7. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
Cornelius F; Mahmmoud YA
Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
[TBL] [Abstract][Full Text] [Related]
8. Competitive inhibition of (Na/K)-ATPase by furylethylenes with respect to potassium ions.
Breier A; Vrbanová A; Docolomanský P; Bohácová V; Ziegelhöffer A
Gen Physiol Biophys; 1996 Aug; 15(4):291-307. PubMed ID: 9088927
[TBL] [Abstract][Full Text] [Related]
9. Effects of chlorpromazine hydrochloride and its metabolites on Mg2+- and Na+,K+-ATPase activities of canalicular-enriched rat liver plasma membranes.
Samuels AM; Carey MC
Gastroenterology; 1978 Jun; 74(6):1183-90. PubMed ID: 148385
[TBL] [Abstract][Full Text] [Related]
10. Characterization of partially purified heart sarcolemmal Na+-K+-stimulated ATPase.
Sulakhe PV; McNamara DB; Dhalla NS
Recent Adv Stud Cardiac Struct Metab; 1976; 9():279-302. PubMed ID: 130658
[TBL] [Abstract][Full Text] [Related]
11. Na+,K+-ATPase activity is inhibited in cultured intestinal epithelial cells by endotoxin or nitric oxide.
Suzuki Y; Lu Q; Xu DZ; Szabó C; Haskó G; Deitch EA
Int J Mol Med; 2005 May; 15(5):871-7. PubMed ID: 15806312
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of renal Na+, K+-adenosine triphosphatase by gentamicin.
Williams PD; Trimble ME; Crespo L; Holohan PD; Freedman JC; Ross CR
J Pharmacol Exp Ther; 1984 Nov; 231(2):248-53. PubMed ID: 6092609
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of aluminum and ouabain on synaptosomal choline uptake, acetylcholine release and (Na+/K+)ATPase.
Silva VS; Nunes MA; Cordeiro JM; Calejo AI; Santos S; Neves P; Sykes A; Morgado F; Dunant Y; Gonçalves PP
Toxicology; 2007 Jul; 236(3):158-77. PubMed ID: 17560001
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of (Na+,K+)-ATPase and Mg++-ATPase by a lysosomotropic drug: perhexiline maleate.
Shacoori V; Leray G; Guenet L; Gueble-Val F; Le Treut A; Le Gall JY
Res Commun Chem Pathol Pharmacol; 1988 Feb; 59(2):161-72. PubMed ID: 2833811
[TBL] [Abstract][Full Text] [Related]
15. Prevention and recovery of (mu(3)-diethylentriamino)-chloro-palladium(II)-chloride induced inhibition of Na/K-ATPase by SH containing ligands--L-cysteine and glutathione.
Krinulović K; Bugarcić Z; Vrvić M; Krstić D; Vasić V
Toxicol In Vitro; 2006 Dec; 20(8):1292-9. PubMed ID: 16697549
[TBL] [Abstract][Full Text] [Related]
16. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.
Paula S; Tabet MR; Ball WJ
Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of omega3 PUFA supplementations on Na,K-ATPase and Mg-ATPase activities: possible role of the membrane omega6/omega3 ratio.
Djemli-Shipkolye A; Raccah D; Pieroni G; Vague P; Coste TC; Gerbi A
J Membr Biol; 2003 Jan; 191(1):37-47. PubMed ID: 12532275
[TBL] [Abstract][Full Text] [Related]
18. Heart sarcolemmal (Na+ + K+)-ATPase has an essential amino group in the potassium binding site on the enzyme molecule.
Breier A; Monosíková R; Ziegelhöffer A; Dzurba A
Gen Physiol Biophys; 1986 Oct; 5(5):537-44. PubMed ID: 3026888
[TBL] [Abstract][Full Text] [Related]
19. Effect of 5-hydroxytryptamine on sodium- and potassium-dependent adenosine triphosphatase and its reactivity toward ouabain.
Stepp LR; Novakoski MA
Arch Biochem Biophys; 1997 Jan; 337(1):43-53. PubMed ID: 8990266
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Na(+) current by diphenhydramine and other diphenyl compounds: molecular determinants of selective binding to the inactivated channels.
Kuo CC; Huang RC; Lou BS
Mol Pharmacol; 2000 Jan; 57(1):135-43. PubMed ID: 10617688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
